|
1
|
Shaw JE, Sicree RA and Zimmet PZ: Global
estimates of the prevalence of diabetes for 2010 and 2030. Diabetes
Res Clin Pract. 87:4–14. 2010. View Article : Google Scholar
|
|
2
|
Raskin P: Why insulin sensitizers but not
secretagogues should be retained when initiating insulin in type 2
diabetes. Diabetes Metab Res Rev. 24:3–13. 2008. View Article : Google Scholar
|
|
3
|
Damsbo P, Vaag A, Hother-Nielsen O and
Beck-Nielsen H: Reduced glycogen synthase activity in skeletal
muscle from obese patients with and without type 2
(non-insulin-dependent) diabetes mellitus. Diabetologia.
34:239–245. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Schalin-Jäntti C, Härkonen M and Groop LC:
Impaired activation of glycogen synthase in people at increased
risk for developing NIDDM. Diabetes. 41:598–604. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Shulman GI, Rothman DL, Jue T, Stein P,
DeFronzo RA and Shulman RG: Quantitation of muscle glycogen
synthesis in normal subjects and subjects with
non-insulin-dependent diabetes by 13C nuclear magnetic
resonance spectroscopy. N Engl J Med. 322:223–228. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Gaster M, Petersen I, Højlund K, Poulsen P
and Beck-Nielsen H: The diabetic phenotype is conserved in myotubes
established from diabetic subjects: Evidence for primary defects in
glucose transport and glycogen synthase activity. Diabetes.
51:921–927. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Henry RR, Ciaraldi TP, Abrams-Carter L,
Mudaliar S, Park KS and Nikoulina SE: Glycogen synthase activity is
reduced in cultured skeletal muscle cells of non-insulin-dependent
diabetes mellitus subjects. Biochemical and molecular mechanisms. J
Clin Invest. 98:1231–1236. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Goodpaster BH, Katsiaras A and Kelley DE:
Enhanced fat oxidation through physical activity is associated with
improvements in insulin sensitivity in obesity. Diabetes.
52:2191–2197. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Nordby P, Auerbach PL, Rosenkilde M,
Kristiansen L, Thomasen JR, Rygaard L, Groth R, Brandt N, Helge JW,
Richter EA, et al: Endurance training per se increases metabolic
health in young, moderately overweight men. Obesity (Silver
Spring). 20:2202–2212. 2012. View Article : Google Scholar
|
|
10
|
Ross R, Dagnone D, Jones PJ, Smith H,
Paddags A, Hudson R and Janssen I: Reduction in obesity and related
comorbid conditions after diet-induced weight loss or
exercise-induced weight loss in men. A randomized, controlled
trial. Ann Intern Med. 133:92–103. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Jensen J, Tantiwong P, Stuenæs JT,
Molina-Carrion M, DeFronzo RA, Sakamoto K and Musi N: Effect of
acute exercise on glycogen synthase in muscle from obese and
diabetic subjects. Am J Physiol Endocrinol Metab. 303:E82–E89.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Manabe Y, Gollisch KS, Holton L, Kim YB,
Brandauer J, Fujii L, Hirshman MF and Goodyear LJ: Exercise
training-induced adaptations associated with increases in skeletal
muscle glycogen content. FEBS J. 280:916–926. 2013.
|
|
13
|
Ryan AS, Ortmeyer HK and Sorkin JD:
Exercise with calorie restriction improves insulin sensitivity and
glycogen synthase activity in obese postmenopausal women with
impaired glucose tolerance. Am J Physiol Endocrinol Metab.
302:E145–E152. 2012. View Article : Google Scholar :
|
|
14
|
Abdul-Ghani MA and DeFronzo RA:
Pathogenesis of insulin resistance in skeletal muscle. J Biomed
Biotechnol. 2010:4762792010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Roach PJ, Depaoli-Roach AA, Hurley TD and
Tagliabracci VS: Glycogen and its metabolism: Some new developments
and old themes. Biochem J. 441:763–787. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Browner MF, Nakano K, Bang AG and
Fletterick RJ: Human muscle glycogen synthase cDNA sequence: A
negatively charged protein with an asymmetric charge distribution.
Proc Natl Acad Sci USA. 86:1443–1447. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Nuttall FQ, Gannon MC, Bai G and Lee EY:
Primary structure of human liver glycogen synthase deduced by cDNA
cloning. Arch Biochem Biophys. 311:443–449. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bolin D, Ahmad M, Banner B, Boros LG, Cai
J, Gillespie P, Goodnow R, Gubler ML, Hamilton MM, Hayden S, et al:
A novel approach for the treatment of type 2 diabetes (T2D):
characterization of a potent, orally active, small molecule
glycogen synthase activator. Presented at 70th ADA Scientific
Sessions; Abstract 1389-P. 2010
|
|
19
|
Qian Y, Bolin D, Conde-Knape K, Gillespie
P, Hayden S, Huang KS, Olivier AR, Sato T, Xiang Q, Yun W, et al:
Design and synthesis of 2-N-substituted indazolone derivatives as
non-carboxylic acid glycogen synthase activators. Bioorg Med Chem
Lett. 23:2936–2940. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Danforth WH: Glycogen synthetase activity
in skeletal muscle. Interconversion of two forms and control of
glycogen synthesis. J Biol Chem. 240:588–593. 1965.PubMed/NCBI
|
|
21
|
Berger J and Hayes NS: A high-capacity
assay for activators of glucose incorporation into glycogen in L6
muscle cells. Anal Biochem. 261:159–163. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Thomas JA, Schlender KK and Larner J: A
rapid filter paper assay for UDPglucose-glycogen
glucosyltransferase, including an improved biosynthesis of
UDP-14C-glucose. Anal Biochem. 25:486–499. 1968.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Nixon JP, Zhang M, Wang C, Kuskowski MA,
Novak CM, Levine JA, Billington CJ and Kotz CM: Evaluation of a
quantitative magnetic resonance imaging system for whole body
composition analysis in rodents. Obesity (Silver Spring).
18:1652–1659. 2010. View Article : Google Scholar
|
|
24
|
Dimopoulos N, Watson M, Green C and Hundal
HS: The PPARdelta agonist, GW501516, promotes fatty acid oxidation
but has no direct effect on glucose utilisation or insulin
sensitivity in rat L6 skeletal muscle cells. FEBS Lett.
581:4743–4748. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sugiyama Y, Taketomi S, Shimura Y, Ikeda H
and Fujita T: Effects of pioglitazone on glucose and lipid
metabolism in Wistar fatty rats. Arzneimittelforschung. 40:263–267.
1990.PubMed/NCBI
|
|
26
|
St Jean DJ Jr and Fotsch C: Mitigating
heterocycle metabolism in drug discovery. J Med Chem. 55:6002–6020.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Jensen J, Rustad PI, Kolnes AJ and Lai YC:
The role of skeletal muscle glycogen breakdown for regulation of
insulin sensitivity by exercise. Front Physiol. 2:1122011.
View Article : Google Scholar
|
|
28
|
Egan B and Zierath JR: Exercise metabolism
and the molecular regulation of skeletal muscle adaptation. Cell
Metab. 17:162–184. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Izumida Y, Yahagi N, Takeuchi Y, Nishi M,
Shikama A, Takarada A, Masuda Y, Kubota M, Matsuzaka T, Nakagawa Y,
et al: Glycogen shortage during fasting triggers
liver-brain-adipose neurocircuitry to facilitate fat utilization.
Nat Commun. 4:23162013.PubMed/NCBI
|
|
30
|
López-Soldado I, Zafra D, Duran J, Adrover
A, Calbó J and Guinovart JJ: Liver glycogen reduces food intake and
attenuates obesity in a high-fat diet-fed mouse model. Diabetes.
64:796–807. 2015. View Article : Google Scholar
|
|
31
|
Kasuga M, Ogawa W and Ohara T: Tissue
glycogen content and glucose intolerance. J Clin Invest.
111:1282–1284. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Clarys JP, Martin AD, Marfell-Jones MJ,
Janssens V, Caboor D and Drinkwater DT: Human body composition: A
review of adult dissection data. Am J Hum Biol. 11:167–174. 1999.
View Article : Google Scholar
|
|
33
|
Ivy JL: Role of carbohydrate in physical
activity. Clin Sports Med. 18:469–484. v1999. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kelley DE, He J, Menshikova EV and Ritov
VB: Dysfunction of mitochondria in human skeletal muscle in type 2
diabetes. Diabetes. 51:2944–2950. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Simoneau JA, Veerkamp JH, Turcotte LP and
Kelley DE: Markers of capacity to utilize fatty acids in human
skeletal muscle: Relation to insulin resistance and obesity and
effects of weight loss. FASEB J. 13:2051–2060. 1999.PubMed/NCBI
|
|
36
|
Mootha VK, Lindgren CM, Eriksson KF,
Subramanian A, Sihag S, Lehar J, Puigserver P, Carlsson E,
Ridderstråle M, Laurila E, et al: PGC-1alpha-responsive genes
involved in oxidative phosphorylation are coordinately
downregulated in human diabetes. Nat Genet. 34:267–273. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Patti ME, Butte AJ, Crunkhorn S, Cusi K,
Berria R, Kashyap S, Miyazaki Y, Kohane I, Costello M, Saccone R,
et al: Coordinated reduction of genes of oxidative metabolism in
humans with insulin resistance and diabetes: Potential role of GC1
and NRF1. Proc Natl Acad Sci USA. 100:8466–8471. 2003. View Article : Google Scholar
|
|
38
|
Toledo FG, Watkins S and Kelley DE:
Changes induced by physical activity and weight loss in the
morphology of inter-myofibrillar mitochondria in obese men and
women. J Clin Endocrinol Metab. 91:3224–3227. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Toledo FG, Menshikova EV, Ritov VB, Azuma
K, Radikova Z, DeLany J and Kelley DE: Effects of physical activity
and weight loss on skeletal muscle mitochondria and relationship
with glucose control in type 2 diabetes. Diabetes. 56:2142–2147.
2007. View Article : Google Scholar : PubMed/NCBI
|
